ELEKTA AB/ADR (OTCMKTS:EKTAY) Lifted to “Hold” at Jefferies Financial Group

Jefferies Financial Group upgraded shares of ELEKTA AB/ADR (OTCMKTS:EKTAY) from an underperform rating to a hold rating in a research report report published on Tuesday morning, The Fly reports. Jefferies Financial Group also issued estimates for ELEKTA AB/ADR’s FY2020 earnings at $0.43 EPS, FY2021 earnings at $0.52 EPS, FY2022 earnings at $0.60 EPS and FY2023 earnings at $0.66 EPS.

A number of other equities analysts have also commented on EKTAY. ValuEngine lowered Woodward, Inc.Common Stock from a buy rating to a hold rating in a research note on Tuesday, April 9th. Zacks Investment Research upgraded Global Ship Lease from a hold rating to a strong-buy rating and set a $7.75 price objective on the stock in a research note on Monday, June 3rd.

ELEKTA AB/ADR stock opened at $13.80 on Tuesday. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 0.62. The business has a 50-day simple moving average of $13.74. The company has a market capitalization of $5.01 billion, a price-to-earnings ratio of 39.43, a PEG ratio of 2.68 and a beta of 0.45. ELEKTA AB/ADR has a 52 week low of $10.95 and a 52 week high of $14.61.

ELEKTA AB/ADR Company Profile

Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.

Featured Article: Why Net Income is Important to Investors

The Fly

Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.